mPharma Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 40
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $18.5M
Latest Deal Amount
  • Investors
  • 22

mPharma General Information

Description

Developer of a pharmaceutical data analytics platform intended to make prescription drugs easily accessible and affordable in emerging markets. The company's platform manages prescription drug inventory for pharmacies and their suppliers and offers them with applications to prescribe and locate the medicines they need and report adverse drug reactions, enabling pharmacies to lower the cost of prescription drugs for patients easily.

Contact Information

Website
www.mpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Business/Productivity Software
Primary Office
  • Accra
  • Ghana

mPharma Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

mPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series C) 10-Apr-2020 $18.5M 000.00 00000 Completed Generating Revenue
8. Grant 15-Apr-2019 00.00 000.00 Completed Generating Revenue
7. Later Stage VC (Series B) 10-Jan-2019 00.00 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series A) 23-Nov-2017 00.00 000.00 000.00 Completed Generating Revenue
5. Early Stage VC (Series A) 08-Jan-2016 00.000 00.000 000.00 Completed Startup
4. Accelerator/Incubator 01-Sep-2015 0000 00000 Completed Startup
3. Early Stage VC (Series A) 08-May-2014 00000 00000 00.00 Completed Startup
2. Accelerator/Incubator 01-Jan-2014 $150K Completed Startup
1. Seed Round 23-Oct-2013 $150K $150K 00.00 Completed Startup
To view mPharma’s complete valuation and funding history, request access »

mPharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C1 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 2 8,198,837 $0.000100 $0.63 $0.63 1x $0.63 18.55%
Seed 1 1,720,774 $0.000100 $0.34 $0.34 1x $0.34 3.89%
To view mPharma’s complete cap table history, request access »

mPharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a pharmaceutical data analytics platform intended to make prescription drugs easily accessible and affordab
Enterprise Systems (Healthcare)
Accra, Ghana
40 As of 2018
000.00
0000 0000-00-00
00000000000 000.00

00000000

irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Except
00000000000 00000000 (000)
Portland, OR
000 As of 0000
00 000000

00000000

derit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupida
000000000000000 00000000
New York, NY
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

mPharma Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LegitScript Private Equity-Backed Portland, OR 000 00 000000
0000000000 Corporation New York, NY
00000 000000 Venture Capital-Backed New York, NY 000 00000 00000000000 00000
0000 (00000 000000 Venture Capital-Backed San Francisco, CA 000 00000 00000000000 00000
To view mPharma’s complete competitors history, request access »

mPharma Executive Team (5)

Name Title Board Seat Contact Info
Gregory Rockson Co-Founder, Chief Executive Officer & Board Member
Nana Dufie Addo Chief Financial Officer
Sophia Baah Chief Operating Officer
James Finucane Co-Founder & Chief Technology Officer
Daniel Shoukimas Co-Founder & Chief Product Officer
To view mPharma’s complete executive team members history, request access »

mPharma Board Members (13)

Name Representing Role Since
Andrew Carruthers mPharma Board Member 000 0000
Andrew Carruthers Novastar Ventures Board Member 000 0000
Chamath Palihapitiya Social Capital Board Member 000 0000
Daniel Vasella mPharma Board Member 000 0000
Gregory Rockson mPharma Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

mPharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

mPharma Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Acuity Ventures Partners Venture Capital Minority 000 0000 000000 0
CDC Group Fund of Funds Minority 000 0000 000000 0
Daniel Vasella Angel (individual) Minority 000 0000 000000 0
Dompé Holdings Family Office Minority 000 0000 000000 0
The Skoll Foundation Not-For-Profit Venture Capital 000 0000 000000 0
You’re viewing 5 of 22 investors. Get the full list »

mPharma Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000000 01-Sep-2019 000000000000000000 000 Distributors (Healthcare)
To view mPharma’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

mPharma Subsidiaries (1)

Company Name Industry Location Founded
0000000 00000000 Distributors (Healthcare) Nairobi, Kenya 0000
To view mPharma’s complete subsidiaries history, request access »